I don't think you'll find many that don't believe .40 is unobtainable. I think the $2.50 mark is attainable if the conference confirms the gene sequence passes to offspring. After this conference, I'm sure they will be discussing buyouts and partnerships with many interested companies, as KBLB has a great technology, but no real infrastructure as of yet to deploy it (that I know of).
yes we can get there no'most of the new shareholders from 0.25 etc..will not sell for only 0.40 but some shareholders are here from less then 0.10 do not forget that...